110 related articles for article (PubMed ID: 38148585)
1. The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort.
Zhang H; Zeng J; Li X; Zhang B; Wang H; Tang Q; Zhang Y; Bao S; Zu L; Xu X; Xu S; Song Z
Cancer Med; 2024 Jan; 13(1):e6751. PubMed ID: 38148585
[TBL] [Abstract][Full Text] [Related]
2. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.
Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q
Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062
[TBL] [Abstract][Full Text] [Related]
3. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer.
Cai JS; Dou XM; Li JB; Yang MZ; Xie CL; Hou X; Yang HX
Semin Thorac Cardiovasc Surg; 2022; 34(3):1040-1048. PubMed ID: 34216749
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database.
Zhang J; Zhang J
BMC Pulm Med; 2023 Oct; 23(1):413. PubMed ID: 37899470
[TBL] [Abstract][Full Text] [Related]
6. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
7. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
8. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
11. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma.
Zhu Z; Wang W; Zha Y; Wang X; Aodeng S; Wang L; Liu Y; Lv W
BMC Cancer; 2024 Feb; 24(1):184. PubMed ID: 38326751
[TBL] [Abstract][Full Text] [Related]
15. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Model to Predict Overall Survival for Lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter Lung Cancer Database.
Wang Z; Hu F; Chang R; Yu X; Xu C; Liu Y; Wang R; Chen H; Liu S; Xia D; Chen Y; Ge X; Zhou T; Zhang S; Pang H; Fang X; Zhang Y; Li J; Hu K; Cai Y
Technol Cancer Res Treat; 2022; 21():15330338221133222. PubMed ID: 36412085
[No Abstract] [Full Text] [Related]
17. Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study.
Chen QL; Li MM; Xue T; Peng H; Shi J; Li YY; Duan SF; Feng F
Clin Radiol; 2023 May; 78(5):e359-e367. PubMed ID: 36858926
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients.
Wang W; Zhou J
Cancer Control; 2023; 30():10732748231197973. PubMed ID: 37703536
[TBL] [Abstract][Full Text] [Related]
19. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database.
Zhang S; Xiao X; Qin X; Xia H
Transl Cancer Res; 2023 Oct; 12(10):2742-2753. PubMed ID: 37969392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]